Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 beta-lactamase production

Antimicrob Agents Chemother. 2003 Mar;47(3):1165-8. doi: 10.1128/AAC.47.3.1165-1168.2003.

Abstract

Two multidrug-resistant Salmonella enterica serovar Wien strains (SW468 and SW1107) were isolated in 2001 in Tunis. Both strains produced the beta-lactamases TEM-1, SHV-2a, and CMY-4, whereas strain SW1107 also produced the beta-lactamase CTX-M-3. The imipenem-resistant strain (SW468) was totally devoid of the OmpF-immunorelated porin. Imipenem resistance was shown as being related to porin loss and CMY-4 beta-lactamase production.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Quinolones
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents / pharmacology
  • Bacterial Outer Membrane Proteins / biosynthesis
  • Bacterial Outer Membrane Proteins / chemistry
  • DNA Primers
  • Drug Resistance, Bacterial
  • Humans
  • Imipenem / pharmacology*
  • Infant, Newborn
  • Plasmids / genetics
  • Porins / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Salmonella enterica / drug effects*
  • Salmonella enterica / genetics
  • Thienamycins / pharmacology*
  • Transformation, Bacterial
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism*

Substances

  • 4-Quinolones
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Bacterial Outer Membrane Proteins
  • DNA Primers
  • OmpF protein
  • Porins
  • Thienamycins
  • Imipenem
  • beta-Lactamases
  • beta-lactamase CMY-4, Salmonella enterica